ANKRD13C-DT
Putative uncharacterized protein ANKRD13C-DT
Also known as: HHLA3_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q9XRX5
- Gene
- ANKRD13C-DT
- Canonical length
- 114 aa
OverviewNCBI Gene
No narrative summary is available for ANKRD13C-DT in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
114 residues, UniProt reviewed canonical sequence.
>Q9XRX5|ANKRD13C-DT
1 MFGACYKQPL KPSGSEPPAE ECRMTPRHAG CDVTEMQRIL SQPTFTEHLL RAVCTKLANM
61 YSTSTDCREH CRRGMKAKQL KAEAGRSCQR KGVPIQTPRE HSWISCKKEF EANPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANKRD13C-DT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANKRD13C-DT as an antibody target. Whether an autoantibody or antibody against ANKRD13C-DT could matter depends on whether native ANKRD13C-DT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANKRD13C-DT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANKRD13C-DT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...